Axsome Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Axsome Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q3 2024.
  • Axsome Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$62.6M, a 0.81% decline year-over-year.
  • Axsome Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$306M, a 58.3% decline year-over-year.
  • Axsome Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$232M, a 28.9% decline from 2022.
  • Axsome Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$180M, a 44.2% decline from 2021.
  • Axsome Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$125M, a 25.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$306M -$62.6M -$504K -0.81% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$306M -$78M -$13M -20% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$293M -$67.3M -$60.9M -955% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$232M -$98.3M -$38.4M -64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 -$193M -$62.1M -$19.7M -46.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$174M -$65.1M -$25.9M -66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$148M -$6.37M +$31.9M +83.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$180M -$59.9M -$27.3M -83.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 -$152M -$42.4M -$9M -27% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$143M -$39.2M -$8.33M -27% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$135M -$38.3M -$10.4M -37.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$125M -$32.6M -$4.86M -17.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 -$120M -$33.4M -$12.3M -58.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$108M -$30.8M -$13.1M -73.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$94.5M -$27.8M +$4.65M +14.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 -$99.1M -$27.7M -$3.32M -13.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$95.8M -$21.1M -$2.18M -11.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$93.6M -$17.8M -$4.33M -32.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$89.3M -$32.5M -$22.1M -212% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$67.2M -$24.4M -$33.9M -358% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$33.4M -$18.9M -$10.7M -130% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$22.7M -$13.4M -$5.46M -68.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$17.2M -$10.4M -$3.26M -45.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$13.9M $9.45M +$3.01M +46.7% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-15
Q3 2018 -$17M -$8.24M -$14.5M -231% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$2.41M -$7.99M -$14.7M -218% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $12.3M -$7.16M -$14.8M -193% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $27.2M $6.44M -$1.18M -15.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $28.3M $6.3M -$910K -12.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-15
Q2 2017 $29.3M $6.75M -$76.5K -1.12% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-15
Q1 2017 $29.3M $7.67M +$1.79M +30.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-15
Q4 2016 $27.5M $7.63M +$4.47M +142% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 $23.1M $7.21M +$5.18M +256% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 $17.9M $6.83M +$4.74M +227% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 $13.1M $5.88M +$3.95M +204% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 $9.2M $3.15M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-07
Q3 2015 $2.02M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-07
Q2 2015 $2.08M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-07
Q1 2015 $1.93M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.